Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4572727
Max Phase: Preclinical
Molecular Formula: C28H27NO5
Molecular Weight: 457.53
Molecule Type: Unknown
Associated Items:
ID: ALA4572727
Max Phase: Preclinical
Molecular Formula: C28H27NO5
Molecular Weight: 457.53
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1ccc(Oc2ccccc2NC(C)=C2C(=O)CC(c3ccccc3)CC2=O)cc1OC
Standard InChI: InChI=1S/C28H27NO5/c1-18(28-23(30)15-20(16-24(28)31)19-9-5-4-6-10-19)29-22-11-7-8-12-25(22)34-21-13-14-26(32-2)27(17-21)33-3/h4-14,17,20,29H,15-16H2,1-3H3/b28-18-
Standard InChI Key: JYHZXWRVJCHCBP-VEILYXNESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 457.53 | Molecular Weight (Monoisotopic): 457.1889 | AlogP: 5.90 | #Rotatable Bonds: 7 |
Polar Surface Area: 73.86 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.74 | CX Basic pKa: | CX LogP: 4.79 | CX LogD: 4.79 |
Aromatic Rings: 3 | Heavy Atoms: 34 | QED Weighted: 0.35 | Np Likeness Score: -0.47 |
1. Bueno O, Gargantilla M, Estévez-Gallego J, Martins S, Díaz JF, Camarasa MJ, Liekens S, Pérez-Pérez MJ, Priego EM.. (2019) Diphenyl ether derivatives occupy the expanded binding site of cyclohexanedione compounds at the colchicine site in tubulin by movement of the αT5 loop., 171 [PMID:30921759] [10.1016/j.ejmech.2019.03.045] |
Source(1):